12 Oct 2020 13:44
Mereo BioPharma Group plc
Â
PDMR Notification
Â
London and Redwood City, Calif., October 12, 2020 - Mereo BioPharma Group plc (NASDAQ: MREO, AIM: MPH), "Mereo" or "the Company", a clinical-stage biopharmaceutical company focused on oncology and rare diseases, received notification that on October 09, 2020, Charles Sermon, General Counsel at Mereo, purchased 18,405 American Depositary Shares (ADSs) at a price of USD 2.41 per ADS.
Â
The below announcement and notification is made in accordance with the EU Market Abuse Regulation. The form required under the EU Market Abuse Regulation follows.
Â
1 | Details of the person discharging managerial responsibilities | |||||
a) | Name | Charles Sermon | ||||
2 | Reason for the notification | |||||
a) | Position/status | General Counsel | ||||
b) | Initial notification/ Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Mereo BioPharma Group plc | ||||
b) | LEI | 213800U8JQHIJOS5AS09 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument and identification code | AMERICAN DEPOSITARY SHARE (ADS) EACH REPRESENTING 5 MEREO BIOPHARMA GROUP PLC ORDINARY SHARES OF £0.003 EACH | ||||
b) | Nature of the transaction | PURCHASE | ||||
c) | Price(s) and volume(s) | Â
  | ||||
d) | Aggregated information: volume, Price | |||||
e) | Date of the transaction | 2020-10-09 | ||||
f) | Place of the transaction | XNMS (Nasdaq Global Market) |
Â